These include ONO-7475 (Ono Pharmaceutical Co), selective for AXL, MER, TYRO3, and FLT3 (127), which will be evaluated in AML and solid tumors (NCT03176277 NCT03730337). Here, AXL is linked to acute myeloid leukemia.